OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Analytical assays ensure that biosimilar CQAs are on track.
Preventing carcinogenic compounds from the pharma supply chain requires coordination.
October 15, 2020
Analysts should understand how a monograph, together with the associated general notices and general chapters, relate to their responsibilities under good manufacturing practices.
October 07, 2020
Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.
The new personal capillary electrophoresis system, Spectrum Compact CE, performs Sanger sequencing and fragment analysis.
The company’s new CytoML Experiment Suite fully automates each stage of the flow cytometry data lifecycle, allowing for clearer data visualization and analysis.
September 02, 2020
Method-transfer kits help simplify analytical method transfer for global site certifications.
Dimethyl sulfoxide is increasingly used in high-risk parenteral and medical device applications that must be manufactured as sterile products in their finished form. A study evaluated the effects four sterilization techniques have on the product quality of this ingredient.
August 28, 2020
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 05, 2020
The use of analytical assays is crucial for determining that biosimilar critical quality attributes remain on point.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.